// App-Quantinova.ai

: Extrafine glycopyrronium bromide (GB) in addition to extrafine beclomethasone dipropionate/formoterol fumarate (BDP/FF) in uncontrolled asthmatic patients

Researchers

Presenter

  • Dave Singh

Principal Investigators

  • George Georges

  • Mario Scuri

  • Ilaria Valente

  • Alessandro Guasconi

  • Francoise Zuccaro

  • Alberto Papi

Medical Centers

  • University of Manchester, Manchester, United Kingdom

  • Chiesi Farmaceutici Inc., Cary, United States of America

  • Chiesi Farmaceutici, S.p.A, Parma, Italy,

  • University of Ferrara, Ferrara, Italy

Locations

  • United Kingdom

  • United States

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • beclomethasone dipropionate/formoterol (NEXT DPI)

  • Glycopyrrolate

  • Formoterol

  • Beclomethasone dipropionate

  • Seebri Breezhaler

Outcome

  • N/A

Study Design

  • Randomized

  • Cross Over

  • Double Blind/Blinded

  • Multicenteric

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved